241 related articles for article (PubMed ID: 22343334)
21. Depleting Antibody Induction and Kidney Transplant Outcomes: A Paired Kidney Analysis.
Sampaio MS; Chopra B; Sureshkumar KK
Transplantation; 2017 Oct; 101(10):2527-2535. PubMed ID: 28475563
[TBL] [Abstract][Full Text] [Related]
22. Effector Memory-Expressing CD45RA (TEMRA) CD8
Doan Ngoc TM; Tilly G; Danger R; Bonizec O; Masset C; Guérif P; Bruneau S; Glemain A; Harb J; Cadoux M; Vivet A; Mai HL; Garcia A; Laplaud D; Liblau R; Giral M; Blandin S; Feyeux M; Dubreuil L; Pecqueur C; Cyr M; Ni W; Brouard S; Degauque N; ;
J Am Soc Nephrol; 2022 Dec; 33(12):2211-2231. PubMed ID: 36280286
[TBL] [Abstract][Full Text] [Related]
23. Chronic Kidney Failure Provokes the Enrichment of Terminally Differentiated CD8
Leonhard J; Schaier M; Kälble F; Eckstein V; Zeier M; Steinborn A
Front Immunol; 2022; 13():752570. PubMed ID: 35592311
[TBL] [Abstract][Full Text] [Related]
24. Characterization of urinary CD4⁺ and CD8⁺ T cells in kidney transplantation patients with polyomavirus BK infection and allograft rejection.
van Doesum WB; Abdulahad WH; van Dijk MC; Dolff S; van Son WJ; Stegeman CA; Sanders JS
Transpl Infect Dis; 2014 Oct; 16(5):733-43. PubMed ID: 25092256
[TBL] [Abstract][Full Text] [Related]
25. Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.
Ruggenenti P; Perico N; Gotti E; Cravedi P; D'Agati V; Gagliardini E; Abbate M; Gaspari F; Cattaneo D; Noris M; Casiraghi F; Todeschini M; Cugini D; Conti S; Remuzzi G
Transplantation; 2007 Oct; 84(8):956-64. PubMed ID: 17989600
[TBL] [Abstract][Full Text] [Related]
26. Delayed allograft inflammation following alemtuzumab induction for kidney transplantation.
Heilman RL; Khamash HA; Smith ML; Chakkera HA; Moss AA; Reddy KS
Clin Transplant; 2013; 27(5):772-80. PubMed ID: 23924146
[TBL] [Abstract][Full Text] [Related]
27. Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.
Pascual J; Pirsch JD; Odorico JS; Torrealba JR; Djamali A; Becker YT; Voss B; Leverson GE; Knechtle SJ; Sollinger HW; Samaniego-Picota MD
Transplantation; 2009 Jan; 87(1):125-32. PubMed ID: 19136902
[TBL] [Abstract][Full Text] [Related]
28. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.
Sewgobind VD; Kho MM; van der Laan LJ; Hendrikx TK; van Dam T; Tilanus HW; IJzermans JN; Weimar W; Baan CC
Nephrol Dial Transplant; 2009 May; 24(5):1635-44. PubMed ID: 19176684
[TBL] [Abstract][Full Text] [Related]
29. Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents.
Levitsky J; Miller J; Wang E; Rosen A; Flaa C; Abecassis M; Mathew J; Tambur A
Hum Immunol; 2009 Mar; 70(3):146-50. PubMed ID: 19141306
[TBL] [Abstract][Full Text] [Related]
30. The development of primed/memory CD8+ lymphocytes in vitro and in rejecting kidneys after transplantation.
Akbar AN; Amlot PL; Timms A; Lombardi G; Lechler R; Janossy G
Clin Exp Immunol; 1990 Aug; 81(2):225-31. PubMed ID: 1974831
[TBL] [Abstract][Full Text] [Related]
31. Immunological profiles of HIV-positive recipients of liver transplant.
Righi E; Ivaldi F; La Rosa A; Carnelutti A; Londero A; Bassetti M
Transpl Immunol; 2019 Dec; 57():101208. PubMed ID: 31102654
[TBL] [Abstract][Full Text] [Related]
32. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
[TBL] [Abstract][Full Text] [Related]
33. Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation.
Ashokkumar C; Shapiro R; Tan H; Ningappa M; Elinoff B; Fedorek S; Sun Q; Higgs BW; Randhawa P; Humar A; Sindhi R
Transplantation; 2011 Aug; 92(4):433-8. PubMed ID: 21747326
[TBL] [Abstract][Full Text] [Related]
34. Terminally differentiated CD8+ Temra cells are associated with the risk for acute kidney allograft rejection.
Betjes MG; Meijers RW; de Wit EA; Weimar W; Litjens NH
Transplantation; 2012 Jul; 94(1):63-9. PubMed ID: 22691956
[TBL] [Abstract][Full Text] [Related]
35. 24-hour immunologic assessment of CD4+ and CD8+ lymphocytes in renal transplant recipients receiving chronic methylprednisolone.
Tornatore KM; Reed K; Venuto R
Clin Nephrol; 1995 Nov; 44(5):290-8. PubMed ID: 8605708
[TBL] [Abstract][Full Text] [Related]
36. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
[TBL] [Abstract][Full Text] [Related]
37. Alemtuzumab induction in deceased donor kidney transplantation.
Huang E; Cho YW; Hayashi R; Bunnapradist S
Transplantation; 2007 Oct; 84(7):821-8. PubMed ID: 17984833
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
[TBL] [Abstract][Full Text] [Related]
39. CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients.
Velthuis JH; Mol WM; Weimar W; Baan CC
Am J Transplant; 2006 Dec; 6(12):2955-64. PubMed ID: 17294523
[TBL] [Abstract][Full Text] [Related]
40. CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients.
Makwana N; Foley B; Fernandez S; Lee S; Irish A; Pircher H; Price P
Eur J Immunol; 2017 Aug; 47(8):1324-1334. PubMed ID: 28586095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
